देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE)
PRO DOC LIMITEE
J05AB11
VALACICLOVIR
500MG
TABLET
VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE) 500MG
ORAL
100
Prescription
NUCLEOSIDES AND NUCLEOTIDES
Active ingredient group (AIG) number: 0128626001; AHFS:
APPROVED
2008-11-06
_PRO-VALACYCLOVIR (Valacyclovir Tablets) page 1 of 39 _ PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR PRO-VALACYCLOVIR Valacyclovir tablets Tablets, 500 mg (as valacyclovir hydrochloride), oral House Standard Antiviral Agent PRO DOC LTÉE 2925 boul. Industriel Laval, Québec H7L 3W9 www.prodoc.qc.ca Submission Control Number: 276404 Date of Initial Authorization: NOV 06, 2008 Date of Revision: JUL 13, 2023 _PRO-VALACYCLOVIR (Valacyclovir Tablets) page 2 of 39 _ RECENT MAJOR LABEL CHANGES Not applicable. TABLE OF CONTENTS SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF AUTHORIZATION ARE NOT LISTED. RECENT MAJOR LABEL CHANGES ......................................................................................................... 2 TABLE OF CONTENTS ............................................................................................................................ 2 PART I: HEALTH PROFESSIONAL INFORMATION ................................................................................... 4 1 INDICATIONS ............................................................................................................................. 4 1.1 Pediatrics ................................................................................................................................... 4 1.2 Geriatrics ................................................................................................................................... 4 2 CONTRAINDICATIONS ................................................................................................................ 4 4 DOSAGE AND ADMINISTRATION ................................................................................................ 4 4.1 Dosing Considerations ............................................................................................................... 4 4.2 Recommended Dose and Dosage Adjustment .......................................................................... 5 4.5 Missed Dose ............................ पूरा दस्तावेज़ पढ़ें